Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-25-001512
Filing Date
2025-01-10
Accepted
2025-01-10 06:02:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 463366
2 logo_001.jpg GRAPHIC 4634
  Complete submission text file 0001493152-25-001512.txt   471176
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-280244 | Film No.: 25520056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)